Leap Therapeutics, INC. (CYPH) — SC 13D/A Filings
All SC 13D/A filings from Leap Therapeutics, INC.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
BeiGene Files SC 13D/A Amendment for Leap Therapeutics
— Oct 31, 2024 Risk: medium
BeiGene, Ltd. filed an amendment (Amendment No. 2) to its Schedule 13D on October 31, 2024, regarding its holdings in Leap Therapeutics, Inc. The filing indicat
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX